The Journal of Gynecologic Oncology (JGO) is an official publication of the Asian Society of Gynecologic Oncology. Abbreviated title is 'J Gynecol Oncol'. It was launched in 1990. The JGO's aim is to publish the highest quality manuscripts dedicated to the advancement of care of the patients with gynecologic cancer. It is an international peer-reviewed periodical journal that is published bimonthly (January, March, May, July, September, and November). Supplement numbers are at times published. The journal publishes editorials, original and review articles, correspondence, book review, etc.
《妇科肿瘤学杂志》 （JGO ）是亚洲妇科肿瘤学会的官方出版物。简称为《妇科肿瘤杂志》。它于1990年推出。JGO的目标是出版最高质量的手稿，致力于提高妇科癌症患者的护理水平。它是一份国际同行评审期刊，每两个月出版一次（1月、 3月、 5月、 7月、 9月和11月）。补充号有时会发布。该杂志发表社论、原创和评论文章、通信、书评等。
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e10
Major clinical research advances in gynecologic cancer in 2018
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e18
The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e13
The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e4
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e57
Dietary inflammatory index and risk of gynecological cancers: a systematic review and meta-analysis of observational studies
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e23
Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e40
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e94
Laparoscopic surgery for low, intermediate and high-risk endometrial cancer
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e24
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e19
Overexpression of HER2/HER3 and clinical feature of ovarian cancer
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e75
Sentinel lymph node mapping in endometrial and cervical cancer: a survey of practices and attitudes in gynecologic oncologists
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e35
Accuracy of frozen section diagnosis and factors associated with final pathological diagnosis upgrade of mucinous ovarian tumors
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e95
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e20
Preoperative chemoradiation followed by hysterectomy for cervical cancer: patterns of care and survival in a large, hospital database
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e41
The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e6
Prognostic factors and effects of fertility-sparing surgery in women of reproductive age with ovarian clear-cell carcinoma: a propensity score analysis
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e102
Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e12
Conservative hysteroscopic treatment of stage I well differentiated endometrial cancer in patients with high surgical risk: a pilot study
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e62
Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e103
Prior uterine myoma and risk of ovarian cancer: a population-based case-control study
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e72
Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e18
Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e19
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e79
Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e7
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e85
Adjuvant chemotherapy in locally advanced cervical cancer: the ceiling remains unbroken
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e97
ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e6
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancer
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e34
Human papillomavirus (HPV) DNA detection in uterine cervix cancer after radiation indicating recurrence: a systematic review and meta-analysis
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e20
Trends in incidence of uterine cancer in Songkhla, Southern Thailand
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e22
Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e11
After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e108
The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e83
Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e96
Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥2 cm: a single-institution, retrospective analysis
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e41
Primary sarcoma of the cervix: an analysis of patient and tumor characteristics, treatment patterns, and outcomes
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e25
Pathologic discrepancies between colposcopy-directed biopsy and loop electrosurgical excision procedure of the uterine cervix in women with cytologic high-grade squamous intraepithelial lesions
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e13
Letter to editor in response to: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e106
Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e117
Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e89
Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e77
Opportunistic salpingectomy in the Netherlands
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e33
Response to comment on: prior uterine myoma and risk of ovarian cancer: a population-based case-control study
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e109
The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e48
Reviewer recognition in 2019
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e110
Clinical significance of variants of unknown significances in BRCA genes
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e80
Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e53
An optimized BRCA1/2 next-generation sequencing for different clinical sample types
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2020.31.e9
The 61st Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO)
来源期刊：Journal of Gynecologic OncologyDOI：10.3802/jgo.2019.30.e114
